Linden Thomas Advisory Services’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.19M Buy
132,915
+14,396
+12% +$237K 0.18% 186
2026
Q1
$1.93M Buy
118,519
+57,608
+95% +$901K 0.19% 202
2025
Q4
$905K Buy
60,911
+2,145
+4% +$30.3K 0.09% 319
2025
Q3
$755K Buy
58,766
+2,399
+4% +$32K 0.08% 346
2025
Q2
$856K Buy
56,367
+26,500
+89% +$413K 0.09% 314
2025
Q1
$499K Buy
29,867
+4,291
+17% +$79K 0.06% 376
2024
Q4
$482K Sell
25,576
-15,321
-37% -$295K 0.06% 386
2024
Q3
$768K Buy
40,897
+5,748
+16% +$110K 0.11% 316
2024
Q2
$664K Buy
35,149
+2,972
+9% +$50.7K 0.1% 320
2024
Q1
$523K Buy
32,177
+9,109
+39% +$133K 0.08% 337
2023
Q4
$292K Buy
23,068
+3,248
+16% +$41K 0.05% 375
2023
Q3
$270K Buy
19,820
+2,097
+12% +$32.4K 0.06% 356
2023
Q2
$304K Buy
+17,723
New +$275K 0.07% 324

Other funds holding SEM

Linden Thomas Advisory Services's SEM Position: Q2 2026 in Review

Linden Thomas Advisory Services increased its Select Medical (SEM) stake by 12% in Q2 2026, buying an estimated $237K and bringing the position to 132,915 shares worth $2.19M. The position accounts for 0.18% of the portfolio, ranked #186.

Linden Thomas Advisory Services first reported a position in SEM in Q2 2023 and has held it in 13 quarters since. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Linden Thomas Advisory Services held 132,915 shares of Select Medical worth $2.19M as of Q2 2026.
  • Linden Thomas Advisory Services bought 14,396 Select Medical shares in Q2 2026, an estimated $237K.
  • Select Medical made up 0.18% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #186 holding.
  • Linden Thomas Advisory Services first reported a position in Select Medical in Q2 2023 and has held it in 13 quarters since.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.